Zobrazeno 1 - 10
of 96
pro vyhledávání: '"Yüksel Ürün"'
Autor:
Hatice Bolek, Cagatay Arslan, Mert Basaran, İrfan Cicin, Mustafa Ozguroglu, Deniz Tural, Yüksel Ürün
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
PURPOSEDurable complete response rates for metastatic renal cell carcinoma (mRCC) and metastatic bladder cancer (mBC) are low despite new therapy. Palliative care focuses on life extension and quality of life (QoL), not cure. This study aims to inves
Externí odkaz:
https://doaj.org/article/cb5cd9d0b8f74576a1727fb5374b5887
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 18 (2024)
Recent progress in adjuvant immunotherapy offers hope for improving disease-free survival in high-risk bladder cancer (BC) and renal cell carcinoma (RCC). This review focuses on key trials such as CheckMate 274 and KEYNOTE-564, which show promising r
Externí odkaz:
https://doaj.org/article/9a7d78314c514077b6d482b9f41504c5
Autor:
Beliz Bahar Karaoğlan, Yüksel Ürün
Publikováno v:
Viruses, Vol 16, Iss 5, p 667 (2024)
Human papillomavirus (HPV), an oncogenic DNA virus, is the most common sexually transmitted virus and significant public health concern globally. Despite the substantial prevalence of HPV infection among men, routine testing remains elusive due to th
Externí odkaz:
https://doaj.org/article/1850d277123f4587a0c939b39ad61a85
Autor:
Kadriye Bir Yücel, Emre Yekedüz, Serdar Karakaya, Deniz Tural, İsmail Ertürk, Cihan Erol, Özlem Ercelep, Nihan Şentürk Öztaş, Çağatay Arslan, Gökhan Uçar, Ahmet Küçükarda, Özlem Nuray Sever, Saadettin Kılıçkap, Orçun Can, Satı Coşkun Yazgan, Berna Öksüzoğlu, Nuri Karadurmuş, Mehmet Ali Şendur, Yüksel Ürün
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract This study aims to investigate the prognostic value of the systemic immune-inflammation index (SII)and its impact on survival in patients with metastatic renal cell carcinoma (mRCC). A total of 706patients with mRCC treated with tyrosine kin
Externí odkaz:
https://doaj.org/article/ff731989e9c14a97850334af8794a507
Publikováno v:
Cam & Sakura Medical Journal, Vol 2, Iss 1, Pp 8-13 (2022)
Objective: To assess the effect of adjuvant chemotherapy on insulin resistance in patients with early breast cancer. Material and Methods: Twenty-three non-diabetic patients were included. Patients were prospectively evaluated before, during, and aft
Externí odkaz:
https://doaj.org/article/11863c170450433285b19bfee728ede7
Autor:
Ali Alkan, Zeynep Gülsüm Güç, Mustafa Gürbüz, Güliz Özgün, Serkan Değirmencioğlu, Mutlu Doğan, Tuğba Akın Telli, Özge Keskin, Çağatay Arslan, Burak Bilgin, Sema Sezgin Göksu, Hacer Demir, Elif Berna Köksoy, Osman Köstek, İsmail Ertürk, Teoman Şakalar, Arzu Yaşar, Görkem Türkkan, Büşra Kasım, Aziz Karaoğlu, Berna Çakmak Öksüzoğlu, Fulden Yumuk, Mehmet Ali Şendur, Hasan Şenol Coşkun, İrfan Çiçin, Nuri Karadurmuş, Özgür Tanrıverdi, Hakan Akbulut, Yüksel Ürün
Publikováno v:
Journal of Men's Health, Vol 17, Iss 4, Pp 128-134 (2021)
Introduction: The efficacy and tolerability of Enzalutamide and Abiraterone Acetate have been reported in elderly patients with metastatic castration resistant prostate cancer (mCRPC). However, there is no randomized study directly comparing antitumo
Externí odkaz:
https://doaj.org/article/b4dace8ad4e24ea2ba76c16fee1bb85f
Publikováno v:
Prostate International, Vol 9, Iss 1, Pp 1-5 (2021)
Prostate cancer (PCa) is the most common cancer in men. Androgen receptor axis plays a crucial role in the carcinogenesis of PCa. The mainstay treatment of prostate cancer is blockage of androgen receptor axis but in a vast majority of patient resist
Externí odkaz:
https://doaj.org/article/11beb8c297064d5eb665086835e82018
Autor:
Yüksel Ürün, Syed A. Hussain, Ziad Bakouny, Daniel Castellano, Saadettin Kılıçkap, Gilberto Morgan, Rana R. Mckay, Kevin Pels, Andrew Schmidt, Deborah B. Doroshow, Fábio Schütz, Laurence Albiges, Gilberto Lopes, James W. F. Catto, Solange Peters, Toni K. Choueiri
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 1248-1257 (2020)
PURPOSE To understand readiness measures taken by oncologists to protect patients and health care workers from the novel coronavirus (COVID-19) and how their clinical decision making was influenced by the pandemic. METHODS An online survey was conduc
Externí odkaz:
https://doaj.org/article/10c712e7f144403792a261a26b22e458
Autor:
Cihan Erol, Emre Yekedüz, Deniz Tural, Serdar Karakaya, Nihan Şentürk Öztaş, Gökhan Uçar, Saadettin Kılıçkap, İsmail Ertürk, Özlem Nuray Sever, Çağatay Arslan, Ahmet Küçükarda, Orçun Can, Özlem Balvan, Satı Coşkun Yazgan, Mustafa Özgüroğlu, Berna Öksüzoğlu, Mehmet Ali Nahit Şendur, Yüksel Ürün
Publikováno v:
Urologia Internationalis. :1-7
Introduction: We aimed to evaluate clinical features, prognostic factors, and treatment preferences in patients with non-clear cell renal cell carcinoma (nccRCC). Methods: Patients with metastatic nccRCC were selected from the Turkish Oncology Group
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9bf0bfca5db9383fcb30bc0a60930218
https://doi.org/10.1159/000528994
https://doi.org/10.1159/000528994
Autor:
Yakup Bozkaya, Nuriye Yıldırım Özdemir, Gökmen Umut Erdem, Ebru Karcı Güner, Yüksel Ürün, Nebi Serkan Demirci, Ozan Yazıcı, Osman Köstek, Nurullah Zengin
Publikováno v:
Journal of Oncological Sciences, Vol 4, Iss 1, Pp 5-10 (2018)
Objective: In this study, our aim was to identify the main predictive factors associated with pathologic complete response (pCR) to neoadjuvantchemoradiotherapy (nCRT) in patients with locally advanced rectal cancer. Methods: The patients who had loc
Externí odkaz:
https://doaj.org/article/70647a291637400dabfdedfe0c13a05f